Reprogramming Tumor Blood Vessels for Enhancing Immunotherapy.

Trends Cancer

The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. Electronic address:

Published: December 2017

Angiogenic blood vessels contribute to generating an immunosuppressive tumor microenvironment, in part by limiting the extravasation of T cells. Functional reprogramming of angiogenic blood vessels, for example through angiopoietin-2 blockade, may improve T cell trafficking in tumors and the efficacy of immune checkpoint blockade (ICB) and other cancer immunotherapies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2017.10.002DOI Listing

Publication Analysis

Top Keywords

blood vessels
12
angiogenic blood
8
reprogramming tumor
4
tumor blood
4
vessels enhancing
4
enhancing immunotherapy
4
immunotherapy angiogenic
4
vessels contribute
4
contribute generating
4
generating immunosuppressive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!